Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serum protein binding of erythromycin and erythromycin 2'-propionate ester.

× No keyword cloud information.

13 in total

Review 1. Antibacterial drugs today. I.

Authors: A P Ball; J A Gray; J M Murdoch
Journal: Drugs Date: 1975 Impact factor: 9.546

2. Blood, tissue, and intracellular concentrations of erythromycin and its metabolite anhydroerythromycin during and after therapy.

Authors: S Krasniqi; P Matzneller; M Kinzig; F Sörgel; S Hüttner; E Lackner; M Müller; M Zeitlinger
Journal: Antimicrob Agents Chemother Date: 2011-11-14 Impact factor: 5.191

Review 3. Protein binding of antimicrobials: clinical pharmacokinetic and therapeutic implications.

Authors: W A Craig; P G Welling
Journal: Clin Pharmacokinet Date: 1977 Jul-Aug Impact factor: 6.447

Review 4. Influence of food and diet on gastrointestinal drug absorption: a review.

Authors: P G Welling
Journal: J Pharmacokinet Biopharm Date: 1977-08

Review 5. A modern view of pharmacokinetics.

Authors: J G Wagner
Journal: J Pharmacokinet Biopharm Date: 1973-10

6. Single-dose fasting bioequivalence assessment of erythromycin stearate tablets in man.

Authors: G J Yakatan; W J Poynor; R G Harris; A Martin; R G Leonard; A H Briggs; J T Doluisio
Journal: J Pharmacokinet Biopharm Date: 1979-08

7. Plasma and salivary concentrations of erythromycin after administration of three different formulations.

Authors: J Henry; P Turner; M Garland; F Esmieu
Journal: Postgrad Med J Date: 1980-10 Impact factor: 2.401

8. [Tissue penetration of erythromycin (author's transl)].

Authors: G A Dette
Journal: Infection Date: 1979 Impact factor: 3.553

9. Pharmacokinetics of single-dose erythromycin in normal and alcoholic liver disease subjects.

Authors: P D Kroboth; A Brown; J A Lyon; F J Kroboth; R P Juhl
Journal: Antimicrob Agents Chemother Date: 1982-01 Impact factor: 5.191

10. Should erythromycin dose be altered in haemodialysis patients?

Authors: A Iliopoulou; K Downey; D M Chaput de Saintonge; P Turner
Journal: Eur J Clin Pharmacol Date: 1982 Impact factor: 2.953